Fwd: High-Dose Fluticasone Effective Against Eosinophilic Esophagitis

---------- Forwarded message ----------
From: National Institute of Allergy and Infectious Diseases (NIAID) <niaid@service.govdelivery.com>
Date: Fri, Jul 18, 2014 at 10:50 AM
Subject: High-Dose Fluticasone Effective Against Eosinophilic Esophagitis
To: iammejtm@gmail.com

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases          Visit us on the Web High-Dose Fluticasone Effective Against Eosinophilic Esophagitis Results from an NIAID-funded clinical trial show that high doses of the corticosteroid fluticasone safely and effectively induce remission in many people with eosinophilic esophagitis (EoE), an inflammatory disease of the esophagus. However, some trial participants did not respond to fluticasone even after six months of high-dose treatments, indicating that certain people with EoE are steroid-resistant. The researchers report their results in the August issue of Gastroenterology. Read more about the study.  Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: National Institute of Allergy and Infectious Diseases · 6610 Rockledge Drive · Bethesda, MD 20892 · 866-284-4107

--
Jeremy Tobias Matthews